
Objective:In order to explore the impact of corona virus disease 2019(COVID-19)on the hospitalization of children with bronchiolitis and to improve clinicians′ understanding of the characteristics of bronchiolitis during the COVID-19 epidemic.Methods:This was a multicenter clinical study, and the data have been collected from 23 children′s medical centers in China.All the clinical data were retrospectively collected from children with bronchiolitis who were hospitalized at each study center from January 1, 2019 to December 31, 2021.The results included gender, age at hospitalization, length of stay, respiratory syncytial virus(RSV) test results, severity rating, ICU treatment, and the total number of children hospitalized with respiratory tract infection during the same period.The clinical data of children with bronchiolitis in 2019 before COVID-19 epidemic and in 2020、2021 during COVID-19 epidemic were statistically analyzed and compared.Results:According to a summary of data provided by 23 children′s medical centers, there were 4 909 cases of bronchiolitis in 2019, 2 654 cases in 2020, and 3 500 cases in 2021.Compared with 2019, the number of bronchiolitis cases decreased by 45.94% in 2020 and 28.70% in 2021.In 2019, 2020 and 2021, there were no significant differences in gender ratio, age, and duration of hospitalization.Compared with 2019, the ratio of bronchiolitis to the total number of hospitalizations for respiratory tract infection decreased significantly in 2020 and 2021( χ2=12.762, P<0.05; χ2=84.845, P<0.05).The proportion of moderate to severe bronchiolitis cases in both 2020 and 2021 was lower than that in 2019, and the difference was statistically significant ( χ2=4.054, P<0.05; χ2=8.109, P<0.05).There was no statistically significant difference in the proportion of bronchiolitis cases requiring ICU treatment between 2019, 2020, and 2021 ( χ2=1.914, P>0.05).In 2019, a total of 52.60%(2 582/4 909) of children with bronchiolitis underwent RSV pathogen testing, and among them, there were 708 cases with RSV positive, accounting for 28.00%.In 2020, 54.14%(1 437/2 654) of children with bronchiolitis underwent RSV pathogen testing, and there were 403 cases with RSV positive, accounting for 28.04%.In 2021, 66.80%(2 238/3 500) of children with bronchiolitis underwent RSV pathogen testing, and there were 935 cases with RSV positive, accounting for 41.78%.Compared with 2019 and 2020, the RSV positive rate in 2021 showed a significant increase( χ2=99.673, P<0.05; χ2=71.292, P<0.05). Conclusion:During the COVID-19 epidemic, the implementation of epidemic prevention and control measures reduced the hospitalization rate and severity of bronchiolitis, but did not reduce the positive rate of RSV detection.
Chemokine receptor 3(CXCR3), a sub chemokine of CXC, is mainly expressed on the surface of activated T cells, B cells and NK cells, and its specific chemokine ligands CXCL9, CXCL10, CXCL11, CXCL4 can induce targeted migration and immune response of target cells, which plays an important role in endothelial cell function, angiogenesis and inhibition.CXCR3 and its ligands have been found to be involved in the progression of cardiovascular diseases in children through various mechanisms including inflammatory chemotaxis, regulation of vascular function and inhibition of fibrosis.They are emerging important biomarkers for various cardiovascular diseases such as heart failure, Kawasaki disease, and hypertension, and are expected to become new targets for the treatment of cardiovascular diseases in children.This article reviews the functions and mechanisms of CXCR3 and its ligands in childhood cardiovascular diseases, in order to provide new ideas for drug development of childhood cardiovascular diseases.
目的:该研究旨在评估创造性音乐疗法改善超早产儿神经发育预后的可行性。方法:在这项可行性试验中,12例超早产儿接受创造性音乐疗法,19例超早产儿接受标准新生儿护理。社会人口学数据和围生期并发症作为危险因素用于组间比较。应用 Mann- Whitney U检验对"贝利婴幼儿发育标准2年随访"(FU2)和"KABC-Ⅱ-Kaufman儿童评估组合5年随访"(FU5)进行分析。 结果:27例(87.1%)和18例(58.1%)超早产儿分别进行FU2和FU5测验。两组出生时的神经发育相关高危因素发生率相似,但创造性音乐疗法组的KABC-Ⅱ指数较高。结论:该研究表明创造性音乐疗法对2岁时的神经发育既无益处也无害处,但5岁时的认知结局有改善的趋势,即创造性音乐疗法组的认知评分较标准治疗组更接近于足月儿。虽然本研究结果值得肯定,但样本量较少且未能随机设计,需谨慎解读。
Kawasaki disease is an acute febrile illness that predominantly affects children under 5 years of age.The pathology is distinguished by small and medium-sized vasculitis.The most severe outcome of this disease is the development of coronary artery lesions, which can result in dilation, stenosis, aneurysm, and potentially long-term progression.MiRNAs, a type of short non-coding RNAs, could directly bind to mRNAs to regulate gene expression at the post-transcriptional level.Numerous studies have demonstrated that miRNAs may play an important role in genetic susceptibility, immunity, inflammatory response, and vascular wall structural abnormalities and dysregulation pertaining to Kawasaki disease.Consequently, comprehensive investigations into targets and pathways influenced by dysregulated miRNAs can facilitate the identification of the molecular mechanism underlying coronary artery lesions, thereby provide insights into early diagnosis, risk prediction, and targeted therapeutic intervention.This review succinctly outlines the involvement of miRNAs in the pathogenesis of coronary artery lesions associated with Kawasaki disease.
While most patients with pre-excitation-induced cardiomyopathy have insidious onset and no obvious clinical symptoms in the early stage, cardiac enlargement and insufficiency often manifest when symptoms appear.The accessory pathway is the primary etiology of pre-excitation-induced cardiomyopathy, and its blockade could result in partial or complete resolution of the left ventricular ejection fraction.Both drug therapy and catheter ablation have been used to treat pre-excitation-induced cardiomyopathy.And the outcome of catheter ablation in pediatric patients has demonstrated a higher rate of success, less incidence of complications and especially notable advancements in the treatment of young children with low body mass due to the development of three-dimensional electro-anatomic mapping technology and the progress in therapy.Moreover, cryoablation is a significant supplement to traditional radiofrequency ablation, which has provided a relatively safe and effective treatment method for pre-excitation-induced cardiomyopathy.This paper reviews the research progress of pre-excitation-induced cardiomyopathy in children.